within Pharmacolibrary.Drugs.ATC.S;

model S01CB04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 15 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Betamethasone is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is commonly used for the treatment of ocular inflammation, allergies, and certain ophthalmic disorders. As S01CB04 (ophthalmologic corticosteroids), it is currently approved and widely used in ophthalmic preparations.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for ophthalmic (topical ocular) administration in adults, as no literature source with detailed PK parameters for topical ocular betamethasone is found.</p><h4>References</h4><ol><li><p>Salminen, L (1990). Review: systemic absorption of topically applied ocular drugs in humans. <i>Journal of ocular pharmacology</i> 6(3) 243–249. DOI:<a href=&quot;https://doi.org/10.1089/jop.1990.6.243&quot;>10.1089/jop.1990.6.243</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2290070/&quot;>https://pubmed.ncbi.nlm.nih.gov/2290070</a></p></li><li><p>Asano, N, et al., &amp; Kawazu, K (2017). Penetration Route of the Selective Glucocorticoid Receptor Agonist SA22465 and Betamethasone into Rabbit Meibomian Gland Based on Pharmacokinetics and Autoradiography. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 45(7) 826–833. DOI:<a href=&quot;https://doi.org/10.1124/dmd.117.075473&quot;>10.1124/dmd.117.075473</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28438780/&quot;>https://pubmed.ncbi.nlm.nih.gov/28438780</a></p></li><li><p>Okabe, K, et al., &amp; Ogura, Y (2007). Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants. <i>Retina (Philadelphia, Pa.)</i> 27(6) 770–777. DOI:<a href=&quot;https://doi.org/10.1097/IAE.0b013e31802ea591&quot;>10.1097/IAE.0b013e31802ea591</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17621189/&quot;>https://pubmed.ncbi.nlm.nih.gov/17621189</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01CB04;
